Pleiotropic Effect of Human ApoE4 on Cerebral Ceramide and Saturated Fatty Acid Levels
- 3 October 2017
- journal article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 60 (3) , 769-781
Abstract
Background: Apolipoprotein E (ApoE) is known for its role in lipid trafficking and the ɛ 4 allele is a risk factor for late onset Alzheimer’s disease (AD). Recently, aberrant ceramide and fatty acid (FA) levels have been implicated in AD. Objective:Keywords
This publication has 83 references indexed in Scilit:
- Ceramide function in the brain: when a slight tilt is enoughCellular and Molecular Life Sciences, 2012
- Goodpasture Antigen-binding Protein/Ceramide Transporter Binds to Human Serum Amyloid P-Component and Is Present in Brain Amyloid PlaquesJournal of Biological Chemistry, 2012
- Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesisBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- Multi-dimensional mass spectrometry-based shotgun lipidomics and the altered lipids at the mild cognitive impairment stage of Alzheimer's diseaseBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- An update on sphingosine-1-phosphate and other sphingolipid mediatorsNature Chemical Biology, 2010
- Deregulation of sphingolipid metabolism in Alzheimer's diseaseNeurobiology of Aging, 2010
- ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brainNeurobiology of Aging, 2009
- Principles of bioactive lipid signalling: lessons from sphingolipidsNature Reviews Molecular Cell Biology, 2008
- Mediterranean Diet, Alzheimer Disease, and Vascular MediationArchives of Neurology, 2006
- A house divided: Ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell deathBiochimica et Biophysica Acta (BBA) - Biomembranes, 2006